PE-backed surgical implants maker Innocoll debuts IPO

Innocoll AG has launched its IPO after pricing its 6.5 million shares at $9 per share. The stock began trading Friday on the NASDAQ under the ticker symbol “INNL.” Piper Jaffray and Stifel were the lead underwriters. Based in Ireland, Innocoll is a pharmaceutical firm that develops surgical implants. Its backers include Cam Investment, Morgan Stanley, NewSmith Opportunities Private Equity Fund and ACL Investments.

133 Views

IPOs boost North America exit activity

IPOs are accelerating private equity exit activity in North America, according to EY’s annual North American PE exit study titled Returning to safer ground: How do private equity investors create value? The report is now in its eighth year and examines the results and methods of 893 exits between 2006 and 2013.

VC-backed Auris Medical prices IPO

Auris Medical Holding has set the pricing terms of its IPO. It plans on selling 6.9 million shares at $10 to $12 per share. The company will trade the stock on the NASDAQ under the ticker symbol “EARS.” Jefferies and Leerink Partners are serving as lead underwriters. Headquartered in Zug, Switzerland, Auris Medical is a biopharmaceutical company focused on otolaryngology. Its backers include Sofinnova Venture Partners, Sofinnova Capital, Adamant Global Generika Funds and Idinvest Partners

127 Views

VC-backed pet insurance firm Trupanion debuts IPO

Trupanion has launched its IPO after pricing its 7.125 million shares at $10 per share. The stock began trading Friday on the NYSE under the ticker symbol “TRUP.” RBC Capital Markets, Barclays and Stifel are the lead underwriters. Based in Seattle, Trupanion is a pet insurance provider. It is backed by Maveron and Highland Capital Partners.

VC-backed TubeMogul cuts IPO pricing terms

According to an amended SEC filing, TubeMogul has reduced its IPO pricing terms. It now plans on selling its IPO of 6.25 million shares between $7 and $8 per share as opposed to an earlier intention of selling it between $11 and $13 per share. The stock will list on the NASDAQ under the ticker symbol “TUBE.” BofA Merrill Lynch, Citigroup, RBC Capital Markets, BMO Capital Markets and Oppenheimer & Co. will serve as lead underwriters. Based in Emeryville, Calif., TubeMogul is an online video marketing company. Its backers include SingTel Innov8, Cross Creek Capital, Digital Advertising Consortium, Foundation Capital and Trinity Ventures.

Roka Bioscience raises $60 mln for IPO

Roka Bioscience has launched its IPO after pricing its 5 million shares at $12 per share. The stock began trading Thursday on the NASDAQ under the ticker symbol “ROKA.” BofA Merrill Lynch and Leerink Partners are the lead underwriters. Based in Warren, NJ, Roka Bioscience is a molecular diagnostics firm focused on detecting foodborne pathogens. Its backers include OrbiMed Advisors, NEA and TPG Biotech.

PEHUB Community

Join the 12500 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

Psst! Got any hot tips?

  • This field is for validation purposes and should be left unchanged.

PE HUB News Briefs

RSS Feed Widget

Marketplace

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget

Reuters VC and PE feed

RSS Feed Widget